Search Results 421-430 of 17861 for Coagulate

1. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

   Must have adequate coagulation, hepatic, renal, and cardiac function: PT/INR and PTT/aPTT < 1.3 × ULN; AST and ALT < 3 × ULN; for participants with leukemic ...

2. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

   coagulation 5. History or presence of clinically relevant central nervous system (CNS) pathology 6. Subject with active or history of plasma cell leukemia ...

3. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   Adequate hematologic, hepatic, renal, and coagulation functions. Exclusion Criteria: Primary uveal or mucosal melanoma; History or evidence of melanoma ...

4. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

   - Coagulation - International normalized ratio (INR) OR prothrombin time (PT) Activated partial thromboplastin time (aPTT) - ≤1.5 × ULN unless participant ...

5. Publications - Victoria Gomez, M.D. - Mayo Clinic

   Endoscopic full-thickness suturing plus argon plasma mucosal coagulation versus argon plasma mucosal coagulation alone for weight regain after gastric bypass: a ...

6. A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer - Mayo Clinic

   Normal coagulation profile. Negative antiviral serology. Female subjects of childbearing potential must not be pregnant or breastfeeding. Willingness to use ...

7. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

   ... coagulation. Subjects with a known medical history of PML. MDS substudy only: Subjects with documented AML (≥ 20% bone marrow or peripheral blood blasts) ...

8. A Study to Compare A-CP HA Kit, Hyaluronic Acid and Placebo To Treatment Knee Osteoarthritis - Mayo Clinic

   Local infection in the affected knee -Hematologic or clotting disorders (thrombocytopenia) or blood coagulation (deficit-blood dyscrasia). Anaemia ...

9. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   Subjects with a risk of clinically significant bleeding events, including those with coagulation or platelet disorders at screening. Subjects with a history ...

10. An update on hemostatic resuscitation - Mayo Clinic

    First, employ thromboelastography, if available, to determine the patient's coagulation status. Some options for supplemental therapy include ...